1.Date of occurrence of the event:2022/11/28
2.Company name: OBI Pharma Inc.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office
4.Reciprocal shareholding ratios: Not applicable
5.Cause of occurrence: The Company announced that OBI forfeited part of the preemptive rights of Obigen’s 2022 cash capital increase and distributed the rights to shareholders of OBI on 2022/11/24. Each thousand shares of OBI bear the subscription rights for 39.1357 shares of Obigen.
Due to the change of amount of shares that can participate in the distribution, it is hereby announced that the subscription rights each thousand shares of OBI bear have changed to 39.10846183 shares of Obigen.
6.Countermeasures: None
7.Any other matters that need to be specified: None